These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 24391291)

  • 1. The Medicines Quality Database: a free public resource.
    Krech LA; El-Hadri L; Evans L; Fouche T; Hajjou M; Lukulay P; Phanouvong S; Pribluda V; Roth L
    Bull World Health Organ; 2014 Jan; 92(1):2-2A. PubMed ID: 24391291
    [No Abstract]   [Full Text] [Related]  

  • 2. The primacy of public health considerations in defining poor quality medicines.
    Newton PN; Amin AA; Bird C; Passmore P; Dukes G; Tomson G; Simons B; Bate R; Guerin PJ; White NJ
    PLoS Med; 2011 Dec; 8(12):e1001139. PubMed ID: 22162953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Counterfeit drugs: an Australian perspective.
    Hensey CC; Gwee A
    Med J Aust; 2016 May; 204(9):344. PubMed ID: 27169964
    [No Abstract]   [Full Text] [Related]  

  • 4. Stemming the global trade in falsified and substandard medicines.
    Gostin LO; Buckley GJ; Kelley PW
    JAMA; 2013 Apr; 309(16):1693-4. PubMed ID: 23579391
    [No Abstract]   [Full Text] [Related]  

  • 5. Substandard and counterfeit antimicrobials: recent trends and implications to key public health interventions in developing countries.
    Tadeg H; Berhane Y
    East Afr J Public Health; 2012 Jun; 9(2):85-9. PubMed ID: 23139963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Counterfeit and Falsified Drugs: an Overview].
    Taverriti-Fortier C; Pape E; Scala-Bertola J; Tréchot P; Maincent P; Gibaja V; Gambier N
    Therapie; 2015; 70(5):455-64. PubMed ID: 26071144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Counterfeit drugs pose growing health threat.
    Traynor K
    Am J Health Syst Pharm; 2010 Nov; 67(22):1896, 1898. PubMed ID: 21048204
    [No Abstract]   [Full Text] [Related]  

  • 8. Counterfeit drug penetration into global legitimate medicine supply chains: a global assessment.
    Mackey TK; Liang BA; York P; Kubic T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):59-67. PubMed ID: 25897059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening global action against poor quality drugs.
    Lancet; 2013 Feb; 381(9867):599. PubMed ID: 23439085
    [No Abstract]   [Full Text] [Related]  

  • 10. Does price reveal poor-quality drugs? Evidence from 17 countries.
    Bate R; Jin GZ; Mathur A
    J Health Econ; 2011 Dec; 30(6):1150-63. PubMed ID: 21917346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Problems associated with substandard and counterfeit drugs in developing countries: a review article on global implications of counterfeit drugs in the era of antiretroviral (ARVs) drugs in a free market economy.
    Nsimba SE
    East Afr J Public Health; 2008 Dec; 5(3):205-10. PubMed ID: 19374325
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor-quality medical products: time to address substandards, not only counterfeits.
    Ravinetto RM; Boelaert M; Jacobs J; Pouget C; Luyckx C
    Trop Med Int Health; 2012 Nov; 17(11):1412-6. PubMed ID: 22909082
    [No Abstract]   [Full Text] [Related]  

  • 13. Monitoring the quality of medicines: results from Africa, Asia, and South America.
    Hajjou M; Krech L; Lane-Barlow C; Roth L; Pribluda VS; Phanouvong S; El-Hadri L; Evans L; Raymond C; Yuan E; Siv L; Vuong TA; Boateng KP; Okafor R; Chibwe KM; Lukulay PH
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):68-74. PubMed ID: 25897073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poor quality drugs: grand challenges in high throughput detection, countrywide sampling, and forensics in developing countries.
    Fernandez FM; Hostetler D; Powell K; Kaur H; Green MD; Mildenhall DC; Newton PN
    Analyst; 2011 Aug; 136(15):3073-82. PubMed ID: 21107455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Counterfeit pharmaceuticals: current status and future projections.
    Wertheimer AI; Chaney NM; Santella T
    J Am Pharm Assoc (2003); 2003; 43(6):710-7; quiz 717-8. PubMed ID: 14717268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Quality of medicines in least developed countries].
    Videau JY
    Med Trop (Mars); 2006 Dec; 66(6):533-7. PubMed ID: 17286015
    [TBL] [Abstract][Full Text] [Related]  

  • 17. WHO Expert Committee on specifications for pharmaceutical preparations.
    World Health Organization Expert Committee
    World Health Organ Tech Rep Ser; 2010; (957):1-276, back cover. PubMed ID: 20560300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The joint interagency task force and the global steering committee for the quality assurance of health products: two new and proactive approaches promoting access to safe and effective medicines.
    Cinnamond M; Woods T
    Am J Trop Med Hyg; 2015 Jun; 92(6 Suppl):133-136. PubMed ID: 26041869
    [No Abstract]   [Full Text] [Related]  

  • 19. Curbing the circulation of counterfeit medicines in Nigeria.
    Fatokun O
    Lancet; 2016 Nov; 388(10060):2603. PubMed ID: 27832872
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of poor-quality medicines in the 'developing' world.
    Newton PN; Green MD; Fernández FM
    Trends Pharmacol Sci; 2010 Mar; 31(3):99-101. PubMed ID: 20117849
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.